GlassScriptPhysician profile
Scott R Serels
NPI 1972695054
$21,683.23
in general payments reported to CMS, 2019-2025
30 companies · $493 in 2025
The $493 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $68.60 · 2021: $648 · 2022: $1,010 · 2023: $3,423 · 2024: $2,111 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,300 · Food and Beverage: $1,671 · Travel and Lodging: $815 · Education: $126 · Gift: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,300.00 |
| Food and Beverage | $1,670.97 |
| Travel and Lodging | $814.63 |
| Education | $125.93 |
| Gift | $115.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $13,458.04 | 2019-2024 | Xtandi |
| Caldera Medical, INC | $4,011.30 | 2019-2024 | Desara |
| Medtronic, INC. | $1,375.08 | 2024-2025 | Altaviva |
| Boston Scientific Corporation | $895.40 | 2019-2024 | Solyx Sis System |
| Teleflex LLC | $308.61 | 2022-2025 | Barrigel, Urolift |
| Procept Biorobotics Corporation | $300.29 | 2024 | Aquabeam System |
| 180 Medical, INC. | $241.39 | 2019-2025 | |
| Axonics, INC. | $221.06 | 2021-2024 | Axonics, Bulkamid |
| Pfizer INC. | $171.85 | 2019-2022 | |
| Urovant Sciences INC | $111.14 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $71.04 | 2023 | |
| Allergan, INC. | $56.14 | 2019-2021 | |
| Abbvie INC. | $47.21 | 2019-2023 | Lupron Depot |
| Myovant Sciences INC. | $46.66 | 2021-2022 | |
| Tesaro, INC. | $42.50 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $36.03 | 2022-2023 | |
| Calyxo, INC. | $33.06 | 2025 | Cvac Aspiration System |
| Acerus Pharmaceuticals Corporation | $27.61 | 2022 | |
| Merck Sharp & Dohme LLC | $25.18 | 2024 | Keytruda |
| Sumitomo Pharma America, INC. | $24.69 | 2025 | Orgovyx |
| Hollister Incorporated | $23.30 | 2022 | |
| Karl Storz Endoscopy-America | $23.14 | 2023 | N.A. |
| Agiliti Surgical, INC. | $22.40 | 2023 | Sonablate, Trinity |
| Tolmar, INC. | $21.53 | 2023 | |
| Coloplast Corp | $19.74 | 2021 | |
| Myriad Genetic Laboratories, INC. | $18.57 | 2023 | Prolaris |
| Urogen Pharma, INC. | $16.97 | 2021 | |
| Janssen Biotech, INC. | $16.66 | 2019 | |
| Verity Pharmaceuticals INC. | $16.64 | 2023 | Trelstar |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,000,024.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Serels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.